News
Find the latest news and press releases of LFB Group and its companies
CELLforCURE will produce innovative cancer CAR-T treatments for Novartis
Denis DELVAL is appointed CEO of LFB SA
The French State proposes Denis Delval as member of the Board in anticipation of his appointment as new LFB Group CEO
LFB’s fibrinogen and 10% immunoglobulin authorized for use in Europe
2017 Rare Disease Day : LFB’s commitment in the field of rare diseases
FDA accepts for review LFB’s BLA for its recombinant Factor VII
INFORMATION RELATING TO LFB S.A. CORPORATE GOVERNANCE
CELLforCURE manufacturing partner of Cellectis for the manufacture of UCART123
Inauguration of new industrial facilities at the LFB biotech plant in Alès (Gard)